More about

Insulin

Clinical Guidance
Type 2 Diabetes
Pharmacologic Intervention

Insulin Therapy

Steven V. Edelman, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Type 2 Diabetes
Pharmacologic Intervention

Bile Acid Sequestrant

Steven V. Edelman, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Type 2 Diabetes
Treatment Guidelines

Assessment of the Treatment Regimen

Steven V. Edelman, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Type 2 Diabetes
Pharmacologic Intervention

Overview of Pharmacologic Therapy

Steven V. Edelman, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
August 07, 2024
3 min read
Save

Large differences observed among insulin algorithms at US academic hospitals

Algorithms for initiating insulin among noncritically ill adults varied widely across 20 U.S. academic hospitals, according to a brief report published in Diabetes Technology & Therapeutics.

News
July 25, 2024
3 min read
Save

Postprandial insulin may cut hypoglycemia rates for hospitalized adults with diabetes

Changing in-hospital nutritional insulin administration from before meals to after meals lowered hypoglycemia rates at a community hospital, according to study findings published in Diabetes Research and Clinical Practice.

News
July 17, 2024
1 min read
Save

Top in endocrinology: Tirzepatide vs. semaglutide; FDA rejects icodec for diabetes

Researchers found that adults with overweight or obesity lost more weight with tirzepatide than semaglutide in a head-to-head comparison of the medications using electronic medical records data.

News
July 11, 2024
1 min read
Save

FDA rejects once-weekly basal insulin for diabetes, requests more information

The FDA declined to approve once-weekly basal insulin icodec for the treatment of diabetes and is requesting more information from Novo Nordisk, according to a company press release.

News
July 05, 2024
2 min read
Save

GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.

News
June 24, 2024
2 min read
Save

Insulin adjustments suggested by mobile app cut HbA1c for adults with type 1 diabetes

ORLANDO — Adults with type 1 diabetes had larger reductions in HbA1c using a mobile app that made recommended adjustments to insulin therapy than users who did not receive weekly adjustments, according to a speaker.

View more